Heart failure with preserved ejection fraction;Insuffisance cardiaque à fraction d'éjection préservée

Presse Medicale

Volumn 37, Issue 7-8, 2008, Pages 1121-1131

  Galinier, Michel ^a  

^a CHU RANGUEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMIODARONE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; DIGOXIN; DIURETIC AGENT; IRBESARTAN; LOSARTAN; NATRIURETIC FACTOR; NICARDIPINE; PERINDOPRIL; PLACEBO; PROPRANOLOL; SPIRONOLACTONE; TOPCAT; URAPIDIL; VERAPAMIL;

CARDIOMYOPATHY; CARDIOVERSION; CHRONOTHERAPY; CHRONOTROPISM; CLINICAL FEATURE; CONFIDENCE INTERVAL; CONTROL GROUP; DIABETES MELLITUS; DISEASE COURSE; DOPPLER ECHOCARDIOGRAPHY; DRUG TOLERANCE; HEART EJECTION FRACTION; HEART FAILURE; HOSPITALIZATION; HUMAN; HYPERTENSION; LUNG EDEMA; MORTALITY; PREVALENCE; PROGNOSIS; RADIOGRAPHY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RESPIRATORY DISTRESS; RISK FACTOR; SHORT SURVEY; STATISTICAL SIGNIFICANCE; TREATMENT DURATION;

ADRENERGIC BETA-ANTAGONISTS; AGE FACTORS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; ECHOCARDIOGRAPHY, DOPPLER; HEART FAILURE; HUMANS; NATRIURETIC PEPTIDES; PULMONARY EDEMA; RISK FACTORS; STROKE VOLUME;

EID: 45549087094     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2007.09.017     Document Type: Short Survey

References (33)

1. Vasan R.S., Benjamin E.J., and Levy D. Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol 26 (1995) 1565-1574
2. Hogg K., Swedberg K., and McMurray J. Heart failure with preserved left ventricular systolic function. Epidemiology, clinical characteristics and prognosis. J Am Coll Cardiol 43 (2004) 317-327
3. Deswal A. Diastolic dysfunction and diastolic heart failure, mechanisms and epidemiology. Curr Cardiol Rep 7 (2005) 178-183
4. Juillière Y., Trochu J.N., de Groote P., and Habib G. Heart failure with preserved systolic function: a diagnostic algorithm for a pragmatic definition. Arch Mal Coeur Vaiss 99 (2006) 279-286
5. Cleland J.G., Tendera M., Adamus J., Freemantle N., Polonski L., Taylor J., and on behalf of PEP-CHF Investigators. The périndopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J 19 (2006) 2338-2345
6. Yusuf S., Pfeffer M.A., Swedberg K., Granger B.C., Held P., McMurray J.J., et al. Effects of Candesartan in patients with CHF and preserved left-ventricular ejection fraction: the Charm-Preserved Trial. Lancet 362 (2003) 777-781
7. Klapholz M., Maurer M., Lowe A.M., Messineo F., Meisner S.J., Mitchell J., et al. Hospitalization for Heart Failure in the Presence of a Normal Left Ventricular. Ejection Fraction. Results of the New York Heart Failure Registry. J Am Coll Cardiol 43 (2004) 1432-1438
8. Vasan R.S., Larson M.G., Benjamin E.J., Evans J.C., Reiss C.K., and Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction. J Am Coll Cardiol 33 (1999) 1948-1955
9. Havranek E.P., Masoudi F.A., Westfall K.A., Wolfe P., Ordin D.L., and Krumholz H.M. Spectrum of heart failure in older patients: Results from the National Heart Failure Project. Am Heart J 143 (2002) 412-417
10. Devereux R.B., Roman M.J., Liu J.E., Welly T.K., Lee E.T., Rodeheffer R., et al. Congestive heart failure despite normal left ventricular systolic function in a population-based sample: The Strong Heart Study. Am J Cardiol 86 (2000) 1090-1096
11. Redfield M.M., Jacobsen S.J., Burnett J.C., Mahonney D.W., Bailey K.R., and Rodeheffer R.J. Burden of systolic and diastolic ventricular dysfunction in the community. Appreciating the scope of the Heart Failure epidemic. JAMA 289 (2003) 194-202
12. Lenzen M.J., Shcolte O.P., Reimer W.J.M., Boersma E., Vantrimpont J.M.J., Follath F., et al. Differences beween patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey. Eur Heart J 25 (2004) 1214-1220
13. Cohen Solal A., Desnos M., Delahaye F., Emeriau J.P., and Hanania G. A national survey of heart failure in French hospitals. Eur Heart J 21 (2000) 763-769
14. Zile M., and Brurtsaert D. New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function. Circulation 105 (2002) 1387-1393
15. Caruana L., Petrie M.C., Davie A.P., and Mcmurray J.V. Do patients with suspected heart fairlure and preserved left ventricular systolic function suffer from "diastolic heart failure or from misdiagnosis"? A prospective descriptive study. Br Med J 321 (2000) 215-219
16. Ghandi S.K., Powers J.C., Nomeir A.M., Fowle K., Kitzmann D.W., Rankin K.M., et al. The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med 344 (2001) 17-22
17. McMurray J., Ostergren J., Pfeffer M., Swedberg K., Granger C., Yusuf P., et al. Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the Candesartan in Heart failure - Assessment of Reduction in Mortality and morbididy Charm programme. Eur J Heart Fail 5 (2003) 261-270
18. Lubien E., Demaria A., Krishnaswamy P., Clopton P., Koon J., Kazanegra R., et al. Utility of B-Natriuretic Peptide in Detecting Diastolic Dysfunction - Comparison With Doppler Velocity Recordings. Circulation 105 (2002) 595-601
19. Maisel A.S., Koon J., Krishnaswamy P., Kazenegra R., Clopton P., GardettoF N., et al. A rapid beside test for brain natriureticpeptide accurately predicts cardiac function in patients referred for echocardiography. Am Heart J 141 (2001) 375-382
20. Tang W.H.W., Girod J.P., Lee M.J., Starling R.C., Young J.B., Van Lente F., et al. Plasma B-type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure. Circulation 108 (2003) 2964-2966
21. Abergel E., and Indices échocardiographiques de fonction diastolique à l'épreuve de la pratique. Arch Mal Coeur Vaiss 98 (2005) 325-330
22. Working Group Report. How to diagnose diastolic heart failure: European Study Group on Diastolic Heart Failure. Eur Heart J. 1998;19:990-1003.
23. Vasan R.S., and Levy D. Defining Diastolic Heart Failure. A call for standardized diagnostic criteria. Circulation 101 (2000) 2118-2121
24. Thomas M.D., Fox K.F., Coats A.J., and Sutton G.C. The epidemiological enigma of heart failure with preserved systolic function. Eur J Heart Fail 6 (2004) 125-136
25. Owan T.E., Hodge D.O., Herges R.M., Jacobsen S.J., Roger V.L., and Redfield M.M. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355 (2006) 251-259
26. Bhatia R.S., Tu J.V., Lee D.S., Austin P.C., Fang J., Haouzi A., et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 355 (2006) 260-269
27. Swedberg K., Cleland J., Dargie H., Drexler H., Follath F., Komajda M., et al. Guidelines for the diagnosis and treatment of chronic heart failire: executive summary (update 2005). The Task Force for the Diagnosis and Treatment of Chronic Hear Failure of the European Society of Cardiology. Eur Heart J 26 (2005) 1115-1140
28. Wachtell K., Bella J.N., Rokkedal J., Palmieri V., Papademetriou V., Dahlöf B., et al. Change in diastolic left ventricular filling after one year of antihypertensive treatment: The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study. Circulation 105 (2002) 1071-1076
29. Fuster V., Rydén L.E., Cannom D.S., Crijns H.J., Curtis A.B., and Ellenbogen K.A. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation- executive summary: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines. Eur Heart J 27 (2006) 1979-2030
30. Hogg K., and McMurray J.J.V. Treatment of heart failure with preserved systolic function: a review of the evidence. Eur Heart J 6 (2004) H61-H66
31. Flather M.D., Shibata M.C., Coats A.J., Van Veldhuisen D.J., Parkhomenko A., Borbola J., et al. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 26 (2005) 215-225
32. Bergström A., Andersson B., Edner M., Nylander E., Persson H., and Dahlström U. Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC). Eur J Heart Fail 6 (2004) 453-461
33. Ahmed A., Rich M.W., Fleg J.L., Zile M.R., Young J.B., Kitzman D.W., et al. Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary Digitalis Investigation Group trial. Circulation 114 (2006) 397-403